Atlas Trials

SOTIO Biotech AG

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SOTIO Biotech AG

RecordFirmDate
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer (NCT06163391)SOTIO Biotech AG2024-05-01
A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer (NCT05619172)SOTIO Biotech AG2022-12-22
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors (NCT05256381)SOTIO Biotech AG2022-06-21
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors (NCT04234113)SOTIO Biotech AG2019-06-13

Track SOTIO Biotech AG automatically

Every clearance here is in the API, with alerts when new ones post.